ISHLT Research Fellowship Grant

Home / Grants & Awards / Grants & Awards
ISHLT Foundation Logo Supported By: The ISHLT Foundation
20 January, 2026 at 11:59 p.m. ET / 21 January, 2026 at 03:59 UTC
Apply Now

The ISHLT Research Fellowship Grant is designed to support trainees pursuing basic, clinical, or translational research in the fields of advanced heart or lung disease, transplantation, mechanical circulatory support, or pulmonary vascular disease (PVD). This funding aims to foster the development of trainees and promote innovative research that advances the science and care of patients in these areas.

Purpose

The ISHLT Research Fellowship Grant will fund an innovative project led by a trainee that advances research in the fields of advanced heart or lung disease, transplantation, mechanical circulatory support, and/or pulmonary vascular disease (PVD). Proposals may involve basic science, clinical, or translational research.

Grant Details

One grant of up to $40,000 USD will be awarded for one year.

Eligibility Requirements
Academic Appointment and Institutional Resources
  1. The applicant must be a trainee who will not have a faculty level appointment (Assistant Professor equivalent or above) or salaried senior staff position (or equivalent) during the period of the grant.
ISHLT Membership
  1. The applicant and the applicant's mentor/research project director must be members of the ISHLT by January 20, 2026.
Previous ISHLT Funding/Funding from Other Sources
  1. There are no restrictions on past or current funding.
  2. If the applicant is currently receiving funding for a project similar to the topics described in this application, the applicant must explain how the funds of the grant would not overlap with the funds of the other research support.
Funding Stipulations / Grant Policies
Please review these guidelines and terms prior to completing your application. If you are ultimately awarded a grant, you will sign a letter of agreement (LOA) stating that you agree to these funding guidelines and terms, and the LOA will be co-signed by your institution’s grant/research office.
 
  1. Research is anticipated to begin within six months of the grant being awarded.
  2. Funding in the amount of up to $40,000 USD will be provided for the research project.
  3. Funding will not be released until visa status is confirmed (if applicable).
  4. The grant is intended to fund salary support for the researcher, other study personnel, statistical support, supplies/materials, core facility use, animals, participant honoraria, publication costs and travel related costs for abstract presentation. Up to 10 percent of the grant can be used for institutional overhead. No other costs are permitted.
  5. The grant will be paid in multiple installments to the recipient's institution. First installment (50% of funds) will be paid at the beginning of grant work; the second installment (25%) will be paid mid-award (after receipt of a grant progress report) and the final installment (25%) will be paid after receipt of a final report.
  6. Grant funding is not transferable from one recipient to another. If the grantee relocates and requests to move the grant to the new institution, the Grants Committee will determine if the grant can be transferred or must be surrendered and any remaining funds returned. A transfer request should be submitted in writing. If the grant is surrendered, a final report will still be required.
  7. The applicant must acknowledge the grant as a funding source in all manuscripts and presentations derived from the funded research using the following statement: “This work was supported by a grant from the International Society for Heart and Lung Transplantation supported by the ISHLT Foundation.” Copies of such publications must be submitted to ISHLT.
  8. Pursuant to regulations of the federal Physician Payment Sunshine Act (included in the Affordable Care Act), NPI numbers will be collected from grant recipients (if applicable), and tax ID numbers collected from the recipients' institutions (if applicable). All payments will be reported to the Centers for Medicare and Medicaid Services Open Payments system, as payments from ISHLT represent indirect transfers of value from the funding pharmaceutical company.
  9. Reports are required at the following intervals depending on the term of the grant, and continuation of funding is contingent upon completion of these reports :
    1. Mid-award progress report due six months after funding begins.
    2. Final report within 30 days of the conclusion of the grant term. A final report is required even if the grant is surrendered for any reason prior to the conclusion of the grant term.
Review Process and Notification
  1. Selection of the grant recipient will be made by an expert review committee. The ISHLT Grants Committee will work with the Interdisciplinary Networks and Professional Communities to identify experts who will review the applications. The Grants Committee will make the final decision about funding.
  2. Grants will be scored on the basis of study aims, significance, innovation, and research approach, as well as the quality of the applicant, the mentor, and the research environment.
  3. All applicants will be notified as to whether or not they have been selected to receive the research grant by 15 March.
  4. For the individual selected, the term of the grant will be one year.